Endometrial cancer Uterine cancer Endometrial Neoplasms Uterine Neoplasms Survival Analysis Prognosis Mortality Retrospective Studies
Conditions
Interventions
Endometrial cancer patients treated surgically at Phrapokklao Hospital 2015-2019
Treatment
endometrial cancar patients
Sponsors
none
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: 1.Patients diagnosed with endometrial cancer. 2.Patients who underwent primary surgical treatment at Phrapokklao Hospital. 3.Patients treated between January 1, 2015 and December 31, 2019. 4.Patients with available medical records containing essential clinical, pathological, treatment, and follow-up information.
Exclusion criteria
Exclusion criteria: 1.Patients with incomplete or missing medical records that are insufficient for analysis. 2.Patients with inadequate follow-up data, defined as less than 12 months of follow-up after completion of primary treatment and without documented survival status or recurrence information. 3.Patients who were lost to follow-up and could not be appropriately censored for survival analysis.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Overall survival From the date of diagnosis until death from any cause or last follow up. Data cut-off date : 31 December 2024 Kaplan-Meier method | — |
Secondary
| Measure | Time frame |
|---|---|
| Disease-Free Survival (DFS) From completion of primary treatment until the first documented recurrence,death, or last follow-up, Data cut-off date : 31 December 2024 Kaplan-Meier method,Prognostic Factors clinical and pathological variables assessed at baseline (diagnosis and primary surgery ) with outcomes monitored until 31 December 2024 chi-square test or Fisher's exact test | — |
Countries
Thailand
Contacts
Public ContactRujira Manorompattarasarn
Department of Obstetrics and Gynecology, Phrapokklao Hospital, Chanthaburi, Thailand
Outcome results
None listed